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The diagnosis of clinically significant oesophageal Candida infections: a reappraisal of clin-
icopathological findings
Aims: Distinguishing true oesophageal Candida infec-
tions from oral contaminants is a common diagnostic
issue. Historically, histological features believed to
indicate true infection included epithelial invasion by
pseudohyphae and intraepithelial neutrophils.
Whether or not these features correlate with endo-
scopic lesions, symptoms and response to therapy has
never been tested in a large cohort. The aim of this
study was to determine whether specific histological
features correlate with clinical and endoscopic find-
ings when Candida is found in oesophageal biopsies.
Methods and results: We reviewed 271 biopsies in
which Candida was detected. Cases were evaluated for
the presence of desquamated epithelial cells, loca-
tion/type of fungal forms, neutrophils, and ulceration.
Medical records were reviewed for clinical history,
endoscopic lesions, and response to antifungal therapy.
Statistical analysis was used to determine whether any
histological features significantly correlated with
clinical variables. There were 120 males and 151
females with a mean age of 42 years. Fifty-nine
per cent had symptoms referable to the oesophagus,
particularly dysphagia (36%). Most (73%) patients had
abnormal endoscopic findings, with plaques, ulcers, or
macroscopic evidence of oesophagitis. Seventy-one per
cent of patients with documented antifungal therapy
showed symptomatic improvement. Overall, there was
no statistically significant correlation between any his-
tological feature and presenting symptoms, endoscopic
findings, or response to therapy. Importantly, the lack
of pseudohyphae, demonstrable invasion of intact
epithelium or neutrophilic infiltrates did not exclude
clinically significant infection.
Conclusions: We conclude that detection of Candida
in oesophageal biopsies is always potentially clinically
significant. Treatment decisions should be made on
the basis of an integration of clinical, endoscopic and
histological findings.
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Introduction
Infectious oesophagitis is the third leading cause of
oesophagitis, following gastro-oesophageal reflux and
eosinophilic oesophagitis.1 Candida infection,
particularly with Candida albicans, is the most com-
mon cause of infectious oesophagitis, with an overall
prevalence of 0.8–7.3%.2–11 Candida is generally con-
sidered to cause an opportunistic infection, resulting
in disease in patients with altered immunity due to
Address for correspondence: E Hissong, Department of Pathology and Laboratory Medicine, New York Presbyterian Hospital, Weill Cornell
Medicine, 525 E. 68th St, New York, NY 10065, USA. e-mail: emh9016@nyp.org
© 2020 John Wiley & Sons Ltd.
Histopathology 2020, 76, 748–754. DOI: 10.1111/his.14063
immunodeficiency, diabetes mellitus, pregnancy,
advanced age, and a number of other disorders asso-
ciated with alterations in the normal components of
the gastrointestinal flora. Affected patients typically
present with odynophagia and/or dysphagia accom-
panied by endoscopically apparent white plaques and
exudates; ulcers and strictures can occur in severe
cases.2,3,11–13 Although exudates are fairly character-
istic of oesophageal candidiasis, they are not uni-
formly present in infected patients, and nor are they
entirely specific for this diagnosis. In fact, the speci-
ficity of upper endoscopic findings for Candida
oesophagitis is only slightly more than 80%, with a
positive predictive value of 89%.14 For this reason,
definite diagnosis relies on pathological confirmation
with cytological brushings, mucosal biopsy, and, in
some cases, fungal cultures.
Oropharyngeal colonisation by Candida occurs in
31–60% of healthy individuals, with highest rates
among those with comorbidities, recent antibiotic
use, and underlying malignancy.15–18 Distinction
between true oesophageal infection and contaminants
from colonised oropharyngeal mucosa is clinically
important, and several histological findings have been
passed down through generations of trainees as indi-
cators of clinically significant oesophageal infection.
These include the presence of pseudohyphae, epithe-
lial invasion by fungi, and detection of intraepithelial
neutrophils, particularly when clustered in the super-
ficial epithelium.7,11,19 However, the significance of
these histological features has never been rigorously
evaluated in a systematic fashion, and nor has there
been any attempt to correlate, in a large cohort, their
presence or absence with clinical symptoms, endo-
scopic lesions, or response to antifungal therapy. We
performed this study to determine whether any speci-
fic histological features are correlated with clinical
symptoms, underlying conditions, endoscopic findings
or treatment response when oesophageal samples
contain Candida.
Materials and methods
C A S E S E L E C T I O N
We retrospectively identified oesophageal biopsy sam-
ples containing Candida from three participating insti-
tutions located on the east coast of the USA, in the
midwestern USA, and in South Africa. The electronic
medical records and endoscopy reports of 271
patients were reviewed for information regarding
comorbidities, presenting symptoms, endoscopic find-
ings, therapeutic interventions, and follow-up data,
when available. Permission for the study was
obtained from the Institutional Review Boards of each
of the participating groups.
H I S T O P A T H O L O G I C A L E V A L U A T I O N
Routinely processed, haematoxylin and eosin (H&E)-
stained tissue sections from all cases were evaluated
by a pathologist at each institution. Each case was
assessed for specific histological features that were
defined and agreed upon by all participating review-
ers. These included the presence of desquamated
epithelial cells and/or keratin debris, reactive epithe-
lial changes (i.e. basal cell hyperplasia, rete peg elon-
gation, and intercellular oedema), location of fungi in
intact epithelium or desquamated debris, morphology
of fungal forms (i.e. budding yeast and/or pseudohy-
phae), the presence of neutrophils in the intact
epithelium, and ulceration. When available, Gomori
methenamine–silver nitrate and/or periodic acid–
Schiff–diastase stains were reviewed, but the determi-
nation of the presence or absence of Candida was
made on H&E-stained sections. Histological findings
were compared with clinical and endoscopic findings
as well as treatment and outcome data.
S T A T I S T I C A L A N A L Y S I S
Fisher’s exact test was used to evaluate the associa-
tions between clinical and histological features. Asso-
ciations with a P-value of <0.05 were considered to
be statistically significant. All analyses were con-
ducted with JMP, Version 14.1 (SAS Institute, Cary,
NC, USA).
Results
The study group consisted of 271 biopsy samples
from individual patients, comprising 120 males and
151 females. Most patients were adults, with a mean
age of 42 years (range, 1–91 years). Clinical and
endoscopic features are summarised in Table 1.
Approximately half (48%) of the study patients had
underlying conditions predisposing them to Candida
infection, most commonly autoimmune diseases
(n = 51, 19%) managed with immunosuppressive
therapy, followed in frequency by concurrent cancer
(14%) and diabetes mellitus (11%). Most (59%)
patients presented with oesophageal symptoms, par-
ticularly dysphagia (36%). Thirteen (5%) patients
complained of odynophagia, and 103 (38%) showed
no symptoms directly referable to the oesophagus.
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The majority (n = 199, 73%) of patients had abnor-
mal endoscopic examination findings, with plaques,
ulcers, or macroscopic evidence of oesophagitis (Fig-
ure 1). The frequency of endoscopic abnormalities did
not differ between patients with and without symp-
toms. Therapeutic interventions with antifungal ther-
apy were documented in 209 (77%) patients. Of
these, 149 (71%) experienced complete resolution of
symptoms or symptomatic improvement after treat-
ment with antifungal agents. Candida infection was
superimposed on a pre-existing or concurrent oeso-
phageal disease in a minority (~30%) of patients. The
most common coexisting oesophageal disease was a
history of reflux (24% of all patients). Twenty
patients with both Candida infection and a history of
reflux were treated with antifungals; of those, 45%
responded to antifungal therapy, and only two had
simultaneous changes made to their anti-reflux ther-
apy dosage. Thus, for at least the vast majority of
cases, symptom resolution, when documented, clini-
cally appeared to be due to antifungal therapy.
The histological features of the study cases are
shown in Table 2. Desquamated epithelial cells
(n = 243, 90%) and pseudohyphae (n = 262, 96%)
were most commonly detected (Figure 2). Ulcers and/
or erosions were identified in 41 (15%) cases. Inva-
sive yeast was observed in intact squamous epithe-
lium in 100 (37%) cases, but this feature did not
significantly correlate with the presence of clinical
symptoms or any endoscopic findings. The only histo-
logical findings that were associated with the pres-
ence of clinical symptoms were reactive epithelial
changes, including basal cell hyperplasia, rete peg
elongation, and/or intercellular oedema, which are
findings similar to those made in reflux-related injury
(78%, P = 0.01). Similarly, reactive epithelial
changes constituted the only histological parameter
that showed a statistically significant association with
endoscopy findings or response to treatment. More-
over, there was no relationship between the histologi-
cal identification of epithelial invasion by fungi and a
clinical response to antifungal agents (Figure 2). In
fact, 64% of patients with a documented response to
antifungal therapy did not have fungal invasion of
the epithelium in their biopsy samples. Only nine
(4%) patients had biopsy samples that featured bud-
ding yeast without pseudohyphae. Six of these
patients had oesophageal symptoms accompanied by
endoscopically apparent plaques (n = 3), ulcers
(n = 1), and oesophagitis (n = 2), including five
patients who experienced symptomatic relief with
antifungal therapy. The relationships between histo-
logical findings, presenting oesophageal symptoms,
endoscopic abnormalities and documented response
to antifungal treatment are summarised in Table 3.
Discussion
To our knowledge, this is the first study of its size that
has tested widely held notions regarding the clinical
significance of various histological findings encoun-
tered in oesophageal samples harbouring Candida, and
has reassessed the diagnostic criteria for oesophageal
candidiasis. We did not find any correlations between
specific histological features and presenting symptoms
or comorbidities, endoscopic findings, or response to
antifungal therapy. Importantly, the lack of pseudohy-
phae or demonstrable invasion of intact epithelium,
long touted as morphological indicators of ‘true’ Can-
dida infection, did not exclude the possibility of
Table 1. Clinical features of patients with Candida
oesophagitis
Total patients (N = 271)




Autoimmune disease 51 (19)





Indication for endoscopy, n (%)
Abdominal pain 37 (14)
Dysphagia 97 (36)
Oesophageal reflux 47 (17)
Anaemia 18 (7)
Barrett’s disease 11 (4)
Odynophagia 13 (5)
Bleeding 12 (4)
Follow-up (other) 17 (6)
Nausea/vomiting 17 (6)
HCV, Hepatitis C virus; HIV, Human immunodeficiency virus.
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clinically significant oesophageal infection. Six (4%) of
our study patients experienced symptomatic relief with
antifungal therapy even though their biopsy samples
contained only budding yeast and/or lacked invasive
fungi in the epithelium. We conclude that detection of
fungal forms in oesophageal biopsy material should
always be considered as being potentially clinically sig-
nificant. In other words, pathologists should not disre-
gard isolated budding yeast in detached debris as oral
contamination, and nor should they require the pres-
ence of neutrophilic inflammation to establish a diag-
nosis of fungal infection. In fact, only slightly over half
of the biopsies (68%) included in this study contained a
neutrophilic infiltrate, and 23% of biopsies with
demonstrable invasion of mucosa did not have associ-
ated neutrophils. Interestingly, patients with neu-
trophils were more likely to be immunosuppressed,
most commonly because of an autoimmune condition.
Candida oesophagitis is an important cause of mor-
bidity, particularly among immunocompromised
patients. Although this disease once showed a
predilection for human immunodeficiency virus-
infected individuals and developed in up to 42% of
these patients, improved retroviral therapy has
resulted in decreased infection rates in this popula-
tion.20 Other risk factors for Candida oesophagitis
include heavy alcohol consumption, hepatitis C viral
infection, syphilis, and medications such as corticos-
teroids, non-steroidal anti-inflammatory drugs, aceta-
minophen, and proton pump inhibitors.6 Recent use
of antibiotic agents, motility disorders, uncontrolled
diabetes mellitus, malnutrition and any process that
diminishes host immunity, alters pH or modifies the
microbial flora of the mucous membranes can also
predispose to oesophageal candidiasis.1,3,5,14–16,21
The mainstay of therapy for Candida oesophagitis is
oral fluconazole, with resolution rates of >90% in
treated patients.10,21–26 However, emerging data sug-
gest that not all patients require therapeutic interven-
tion.27,28 Lee et al. evaluated 141 asymptomatic
patients with Candida oesophagitis, and found that
81% showed resolution of oesophageal inflammation
on follow-up endoscopy, even though most were not
treated with antifungal therapy.28 Hoversten et al.
reported similar findings. In their study of 218
patients with Candida in oesophageal biopsy samples,
92% of untreated patients showed resolution of lesions
at interval endoscopy. Of the 74 asymptomatic
patients who did not receive a therapeutic interven-
tion, most (91%) remained asymptomatic, and all
patients (n = 12) who underwent follow-up endoscopy
showed resolution of oesophageal inflammation.29
Although these data suggest that asymptomatic Can-
dida oesophagitis is of little clinical significance in
some patients, criteria for distinguishing patients who
require therapy from those who do not remain
unclear; asymptomatic patients can certainly have
endoscopically apparent oesophagitis with exudates
and fungi in oesophageal biopsy samples. Oesophageal
biopsies with Candida are usually described as contain-
ing budding yeast and/or pseudohyphae, variably
A B
Figure 1. Most patients with abnormal endoscopic findings had yellow–white exudates in a focal (A) or a diffuse, circumferential distribu-
tion; the latter were frequently associated with ulcers (B).
Table 2. Histological findings in all oesophageal biopsies
with Candida
Histological findings
All biopsies (N = 271), n
(%)
Presence of budding yeast 219 (81)
Epithelial neutrophilic infiltrate 184 (68)
Yeast in intact squamous epithelium 100 (37)
Presence of pseudohyphae 262 (96)
Desquamated epithelial cells and
keratin
243 (90)
Reactive epithelial changes 195 (72)
Ulceration 41 (15)
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present neutrophilic and/or lymphocytic infiltrates,
superficial exudates of desquamated epithelial cells,
and reactive squamous epithelial changes that may
mimic other types of oesophagitis.5,19,30 Historically,
many pathologists have required the presence of pseu-
dohyphae and/or fungal invasion of intact epithelium
to establish a diagnosis of clinically significant infec-
tion, but our data show that patients with clinically
significant infections often lack these features. In addi-
tion, desquamated tissue fragments and detached
yeast may be lost as a result of prior cytological
brushings or during tissue processing.11,31 In these
situations, other histological changes, such as reactive
epithelial changes or intraepithelial neutrophils, may
be helpful diagnostic clues.2,30,32 However, approxi-
mately one-quarter of the patients in our study had
oesophageal biopsies that showed fungal invasion of
the squamous epithelium unaccompanied by neu-
trophil-rich inflammation.
The results of this study indicate that the histologi-
cal features of oesophageal Candida infection are vari-
able and do not correlate well with either clinical or
endoscopic findings. They also suggest that the histor-
ical question regarding the distinction of clinically
significant infection from oral flora is probably not
within the sole purview of pathologists. Our data
show that detection of Candida is rarely a clinically
A B
C D
Figure 2. Samples from four symptomatic patients with endoscopically identified oesophageal plaques and a response to antifungal therapy
feature variably severe abnormalities. Some cases featured squamous hyperplasia with intraepithelial neutrophils, desquamation, and bud-
ding yeast with pseudohyphae in both desquamated and intact epithelium (A). Others featured superficially invasive yeast unaccompanied
by inflammation (B). Some patients with yeast confined to desquamated keratin debris responded to antifungal therapy (C). Another patient
with endoscopically apparent plaques had mostly unremarkable squamous mucosa (D); a few budding yeast without pseudohyphae were
limited to desquamated epithelium (see inset).
Table 3. Histological findings in oesophageal biopsies of
symptomatic patients, those with endoscopic abnormalities,


















126 (80) 159 (80) 117 (79)
Epithelial neutrophilic
infiltrate
114 (73) 142 (71) 94 (63)
Yeast in intact
squamous epithelium
60 (38) 76 (38) 53 (36)
Presence of
pseudohyphae
151 (96) 192 (96) 133 (89)
Desquamated epithelial
cells and keratin
143 (91) 184 (92) 125 (84)
Reactive epithelial
changes*
122 (78) 152 (76) 126 (85)
Ulceration 25 (16) 25 (13) 22 (15)
*This was the only histological finding that showed a statistically
significant association with clinical symptoms (P = 0.013), endo-
scopic abnormalities (P = 0.035), or response to antifungal treat-
ment (P = 0.014).
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insignificant finding, even if only budding yeast is
identified in oesophageal biopsy samples. For this rea-
son, pathologists should determine whether yeast is
present in oesophageal biopsy samples, but they can-
not confirm or exclude clinically significant Candida
infection, particularly among immunocompromised
patients. The ultimate decision to treat Candida infec-
tion with antifungal therapy should be made on the
basis of the integration of clinical, endoscopic and
histological findings.
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